Community-associated Meticillin-resistant Staphylococcus Aureus Carriage in Hospitalized Patients in Tropical Northern Australia
Overview
Infectious Diseases
Affiliations
Background: Community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) was first reported in remote Australian Aboriginal communities. It is a prominent clinical pathogen in northern Australia with potential for transmission within the local hospital setting.
Aim: To determine epidemiological characteristics of S. aureus carriage within the Royal Darwin Hospital.
Methods: We screened two patient groups: an 'admission group' recruited within 48 h of admission; and an 'inpatient group' recruited five or more days after admission. S. aureus isolates were characterized by antibiotic susceptibility testing and genotyped by a multi-locus sequence type-based high-resolution melting scheme.
Findings: S. aureus carriage on admission was 30.7% of 225 compared with 34.8% among 201 inpatients, with MRSA carriage of 2.2% and 18.9% respectively. We isolated CA-MRSA from 0.9% and 10.4%, and healthcare-associated (HCA)-MRSA from 1.3% and 9.0% of the admission and inpatient groups, respectively. Among the inpatient group, hospital-associated ST239 was the most common MRSA strain. CA-MRSA was represented by one clonal complex (CC) in the admission group (CC5) and seven CCs in the inpatient group (CC1, 93, 5, 6, 30, 75, 88).
Conclusion: Inpatient carriage of multiple CA-MRSA lineages suggests selection for and transmission within the hospital of not only typical HCA-MRSA, but also diverse CA-MRSA strains.
McGuinness S, Holt D, Harris T, Wright C, Baird R, Giffard P mSphere. 2021; 6(1).
PMID: 33568451 PMC: 8544886. DOI: 10.1128/mSphere.00651-20.
Trends in Bacteremia Over 2 Decades in the Top End of the Northern Territory of Australia.
Douglas N, Hennessy J, Currie B, Baird R Open Forum Infect Dis. 2020; 7(11):ofaa472.
PMID: 33204758 PMC: 7651056. DOI: 10.1093/ofid/ofaa472.
Su M, Qiu L, Deng Y, Ruiz C, Rudolf J, Dong L Mol Pharm. 2019; 16(7):3065-3071.
PMID: 31244223 PMC: 6763203. DOI: 10.1021/acs.molpharmaceut.9b00293.
Wong J, Ip M, Tang A, Wei V, Wong S, Riley S Clin Epidemiol. 2018; 10:1489-1501.
PMID: 30349396 PMC: 6190640. DOI: 10.2147/CLEP.S160595.
Sahibzada S, Hernandez-Jover M, Jordan D, Thomson P, Heller J PLoS One. 2018; 13(5):e0195510.
PMID: 29718930 PMC: 5931470. DOI: 10.1371/journal.pone.0195510.